<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(9)</volume><submitter>Wada H</submitter><pubmed_abstract>Background VEGF-D (vascular endothelial growth factor D) and VEGF-C are secreted glycoproteins that can induce lymphangiogenesis and angiogenesis. They exhibit structural homology but have differential receptor binding and regulatory mechanisms. We recently demonstrated that the serum VEGF-C level is inversely and independently associated with all-cause mortality in patients with suspected or known coronary artery disease. We investigated whether VEGF-D had distinct relationships with mortality and cardiovascular events in those patients. Methods and Results We performed a multicenter, prospective cohort study of 2418 patients with suspected or known coronary artery disease undergoing elective coronary angiography. The serum level of VEGF-D was measured. The primary outcome was all-cause d</pubmed_abstract><journal>Journal of the American Heart Association</journal><pagination>e015761</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7428571</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Distinct Characteristics of VEGF-D and VEGF-C to Predict Mortality in Patients With Suspected or Known Coronary Artery Disease.</pubmed_title><pmcid>PMC7428571</pmcid><pubmed_authors>Yonezawa K</pubmed_authors><pubmed_authors>Shimizu M</pubmed_authors><pubmed_authors>Suzuki M</pubmed_authors><pubmed_authors>Sakagami S</pubmed_authors><pubmed_authors>Morita Y</pubmed_authors><pubmed_authors>Funada J</pubmed_authors><pubmed_authors>Shimatsu A</pubmed_authors><pubmed_authors>Shinozaki T</pubmed_authors><pubmed_authors>Takagi D</pubmed_authors><pubmed_authors>Iguchi M</pubmed_authors><pubmed_authors>Akao M</pubmed_authors><pubmed_authors>Matsuda M</pubmed_authors><pubmed_authors>Takenaka T</pubmed_authors><pubmed_authors>Satoh-Asahara N</pubmed_authors><pubmed_authors>Unoki T</pubmed_authors><pubmed_authors>ANOX Study Investigators</pubmed_authors><pubmed_authors>Hasegawa K</pubmed_authors><pubmed_authors>Kotani K</pubmed_authors><pubmed_authors>Ishii M</pubmed_authors><pubmed_authors>Ajiro Y</pubmed_authors><pubmed_authors>Yamakage H</pubmed_authors><pubmed_authors>Wada K</pubmed_authors><pubmed_authors>Kusakabe T</pubmed_authors><pubmed_authors>Kato T</pubmed_authors><pubmed_authors>Fujimoto K</pubmed_authors><pubmed_authors>Wada M</pubmed_authors><pubmed_authors>Yasoda A</pubmed_authors><pubmed_authors>Masunaga N</pubmed_authors><pubmed_authors>Abe M</pubmed_authors><pubmed_authors>Wada H</pubmed_authors><pubmed_authors>Nakamura T</pubmed_authors><pubmed_authors>Matsubara H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Distinct Characteristics of VEGF-D and VEGF-C to Predict Mortality in Patients With Suspected or Known Coronary Artery Disease.</name><description>Background VEGF-D (vascular endothelial growth factor D) and VEGF-C are secreted glycoproteins that can induce lymphangiogenesis and angiogenesis. They exhibit structural homology but have differential receptor binding and regulatory mechanisms. We recently demonstrated that the serum VEGF-C level is inversely and independently associated with all-cause mortality in patients with suspected or known coronary artery disease. We investigated whether VEGF-D had distinct relationships with mortality and cardiovascular events in those patients. Methods and Results We performed a multicenter, prospective cohort study of 2418 patients with suspected or known coronary artery disease undergoing elective coronary angiography. The serum level of VEGF-D was measured. The primary outcome was all-cause d</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 May</publication><modification>2025-04-18T14:54:47.14Z</modification><creation>2025-04-07T01:17:09.79Z</creation></dates><accession>S-EPMC7428571</accession><cross_references><pubmed>32319336</pubmed><doi>10.1161/JAHA.119.015761</doi></cross_references></HashMap>